Imprivata enters into contract with Texas Instruments

By Admin
Leader in healthcare IT security Imprivata and Texas Instruments Incorporated has signed an agreement to support strong authentication and secure appli...

Leader in healthcare IT security Imprivata and Texas Instruments Incorporated has signed an agreement to support strong authentication and secure application access from virtual desktop environments.

The solution, combining TI’s DM8148 system-on-chip and Imprivata OneSign will enable manufacturers to provide out-of-the-box strong user authentication into any software application delivered through a thin-or-zero-client endpoint.

This type of integrated technology is attractive in healthcare, where the highly mobile care providers need fast, secure access to sensitive patient information on shared devices.

The Texas Instrument’s cost-effective DM8148 SoC drives optimized virtual capabilities in power efficient and secured manner.

The SoC drives the optimized virtual desktop capabilities in the secured and power efficient manner. It also supports dual-displays running concurrently upto 1920x1200 resolution.

The DM8148 also supports the leading Virtual Desktop Infrastructure protocols for ultimate flexibility. The low-power SoC enables OEMs to create a fanless design that yields greater reliability and lower maintenance for thin-client systems.

Texas Instruments has also developed a software reference design kit for thin and zero clients. Through its partnership with TI, Imprivata enables thin and zero client vendors to embed Imprivata OneSign strong authentication functionality directly into their devices incorporating the TIDM8148 SoC. 

Imprivata is the number one provider of secure access solutions for healthcare. By strengthening user authentication, streamlining application access and simplifying compliance reporting across multiple computing environments,  the customers realize improved workflows, increased  security and compliance along with government regulations.
 

Share
Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma